ZTS:
The current market price is 122.93, reflecting a 0.0% change from the previous close.
Support and Resistance Levels
Support levels are 121.93, 121.34, and 121.00; resistance levels are 123.08, 123.51, and 124.00, with a pivot point at 122.56.
Indicators
The RSI indicates overbought conditions at 100. The ADX is at 100, showing strong trend strength. The 50-day SMA is at 123.00, indicating a bullish trend, while the ATR is decreasing, suggesting lower volatility.
Market Sentiment
The pivot point is at 122.56, indicating a bullish scenario as the price is above it, supported by the RSI, ADX, and SMA trends.
---
ZTS Signals & Technical Analysis
Last Updated: <% indicators.interval.updated|date:'MMM d, y h:mm:ss a' %>
Zoetis Inc. (NYSE: ZTS) is a leading global animal health company headquartered in Parsippany, New Jersey, United States. Founded in 1952 as a subsidiary of the pharmaceutical giant IDEXX Laboratories, Zoetis became an independent entity in 2013. The company specializes in the discovery, development, and production of veterinary vaccines and medicines for both companion animals and livestock.
Market Position
As one of the largest players in the animal health sector, Zoetis holds a significant market share, supported by a diverse portfolio of products, which includes vaccines, dermatology solutions, anesthesia, and anti-infectives. The company operates in over 100 countries worldwide and serves veterinarians, farmers, and animal producers. With a strong commitment to innovation, Zoetis invests heavily in research and development, aiming to provide cutting-edge solutions that enhance animal health and productivity.
Key Financial Highlights
In 2022, Zoetis reported revenues of approximately $7.8 billion, reflecting steady growth driven by increased demand for pet care products and livestock health solutions. The company has consistently demonstrated strong financial performance, boasting a healthy operating margin and a commitment to returning value to shareholders through dividends and strategic acquisitions. As of the latest reports, Zoetis maintains a robust balance sheet with a strong cash flow, enabling continued investment in research and strategic growth initiatives.
Industry Highlights
The global animal health market is projected to experience substantial growth, driven by trends such as increased pet ownership, a rising focus on food safety, and advancements in veterinary medicine. Zoetis is well-positioned to capitalize on these trends, leveraging its extensive research capabilities and innovative product offerings. The company's strategic initiatives aim to expand its presence in emerging markets and enhance its product pipeline, ensuring sustained growth and market leadership in the dynamic animal health industry.
<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
